How UCDavis Health is Advancing Cancer Research
Cancer research has been a focal point for many universities and research organizations. Despite the advancements, cancer remains a significant public health concern worldwide. According to the World Health Organization (WHO), cancer is the second leading cause of death globally and is responsible for approximately 9.6 million deaths in 2018. UCDavis Health is one organization committed to advancing cancer research. This article aims to highlight the different initiatives taken by UCDavis Health to fight against cancer.
UCDavis Health’s Comprehensive Cancer Center
The UCDavis Comprehensive Cancer Center (CCC) was started in 1974 and is one of only 51 cancer centers in the United States with the National Cancer Institute (NCI) designation of “comprehensive.” This designation recognizes the CCC’s outstanding efforts in cancer research, education, and patient care.
The center’s research efforts span across a broad range of cancer types, including breast cancer, prostate cancer, leukemia, lung cancer, lymphoma, and multiple myeloma. The researchers at CCC use cutting-edge technology and innovative approaches to understand the biology of cancer and develop treatments for patients. They also conduct clinical trials to test new treatments and therapies for cancer patients.
Investing in Big Data
UCDavis Health has invested heavily in big data and artificial intelligence (AI) to improve cancer diagnosis and treatment. The team at CCC uses data from a variety of sources, including electronic health records, medical imaging, and genomic data, to create a better understanding of cancer at the molecular and cellular levels. By analyzing big data, CCC researchers can develop personalized cancer treatments tailored to each patient’s unique biology.
UCDavis Health is also using AI-assisted imaging to detect cancer at earlier stages. The AI system developed at UCDavis can detect early-stage breast cancer in mammograms with up to 95% accuracy. Early detection significantly improves the chances of successful treatment and survival.
Collaboration with other Institutions
UCDavis Health understands the importance of collaboration in cancer research. The institution works closely with other leading cancer centers, including the Mayo Clinic, Memorial Sloan Kettering Cancer Center, and Fred Hutchinson Cancer Research Center, to develop groundbreaking cancer treatments. The institution has also formed partnerships with non-profit organizations, advocacy groups, and other universities worldwide to advance cancer research.
Conclusion
Cancer is a complex disease, and it would take coordinated efforts to develop treatments that improve patient outcomes. UCDavis Health’s comprehensive cancer center, investment in big data, and collaboration with other institutions are all steps towards solving the cancer puzzle.
Furthermore, the development of AI-assisted imaging and personalized treatments could potentially change the way we diagnose and treat cancer completely.
UCDavis Health is a trailblazer in cancer research, and with its continued efforts, many patients may be diagnosed earlier and receive treatment that could significantly improve their chances of survival.
